Loading the player… “It saddens me that when I tell people I have sickle cell the most common reply is ‘what is that?’” sickle cell advocate Shamonica Wiggins shares with theGrio. Sickle cell disease (SCD) is a group of red blood cell disorders occurring when a child inherits the sickle cell gene from both parents… Read More »
A woman’s supply of eggs is finite, so it is crucial that the quality of their genetic material is ensured. New work from Carnegie’s Marla Tharp, Safia Malki, and Alex Bortvin elucidates a mechanism by which, even before birth, the body tries to eliminate egg cells of the poorest quality. Their findings describing this mechanism… Read More »
FDA Approves Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease Print this page November 25, 2019 — Today, the U.S. Food and Drug Administration granted accelerated approval to Oxbryta (voxelotor) for the treatment of sickle cell disease (SCD) in adults and pediatric patients 12 years of age and older. “Today’s approval provides additional hope… Read More »
(Reuters) – The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc to treat sickle cell disease in adults and children 12 years or older. The treatment will be priced at $ 10,417 per month, or around $ 125,000 per year, and will be sold under the… Read More »
This undated image provided by Novartis shows bottles of Novartis’s Adakveo. U.S. regulators have approved the new sickle cell disease medicine that can prevent extremely painful, dangerous “crises” in which misshapen blood cells clump together, reducing blood and oxygen flow. (Novartis via AP) After a recent decision by the FDA a better day could be… Read More »